| Literature DB >> 25130867 |
Jeremy Schwartzentruber1, Daniela Buhas, Jacek Majewski, Florin Sasarman, Simon Papillon-Cavanagh, Isabelle Thiffault, Isabelle Thiffaut, Katherine M Sheldon, Christine Massicotte, Lysanne Patry, Mariella Simon, Amir S Zare, Kevin J McKernan, Jacques Michaud, Richard G Boles, Cheri L Deal, Valerie Desilets, Eric A Shoubridge, Mark E Samuels.
Abstract
Mutations in the nuclear-encoded mitochondrial aminoacyl-tRNA synthetases are associated with a range of clinical phenotypes. Here, we report a novel disorder in three adult patients with a phenotype including cataracts, short-stature secondary to growth hormone deficiency, sensorineural hearing deficit, peripheral sensory neuropathy, and skeletal dysplasia. Using SNP genotyping and whole-exome sequencing, we identified a single likely causal variant, a missense mutation in a conserved residue of the nuclear gene IARS2, encoding mitochondrial isoleucyl-tRNA synthetase. The mutation is homozygous in the affected patients, heterozygous in carriers, and absent in control chromosomes. IARS2 protein level was reduced in skin cells cultured from one of the patients, consistent with a pathogenic effect of the mutation. Compound heterozygous mutations in IARS2 were independently identified in a previously unreported patient with a more severe mitochondrial phenotype diagnosed as Leigh syndrome. This is the first report of clinical findings associated with IARS2 mutations.Entities:
Keywords: IARS2; exome sequencing; mitochondrial disorder; mitochondrial tRNA synthetase
Mesh:
Substances:
Year: 2014 PMID: 25130867 DOI: 10.1002/humu.22629
Source DB: PubMed Journal: Hum Mutat ISSN: 1059-7794 Impact factor: 4.878